197 related articles for article (PubMed ID: 32144897)
1. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer.
Aagaard T; Reekie J; Jørgensen M; Roen A; Daugaard G; Specht L; Sengeløv H; Mocroft A; Lundgren J; Helleberg M
Cancer Med; 2020 May; 9(9):3033-3042. PubMed ID: 32144897
[TBL] [Abstract][Full Text] [Related]
2. Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit.
Cetintepe T; Cetintepe L; Solmaz S; Calık S; Ugur MC; Gediz F; Bilgir O
Support Care Cancer; 2021 Jul; 29(7):4089-4094. PubMed ID: 33404806
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013.
Gheerbrant H; Timsit JF; Terzi N; Ruckly S; Laramas M; Levra MG; Jacquet E; Falque L; Moro-Sibilot D; Toffart AC
BMC Cancer; 2021 Jan; 21(1):9. PubMed ID: 33402107
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit.
Ko H; Yan M; Gupta R; Kebbel K; Maiti A; Song J; Nates J; Overman MJ
Oncologist; 2019 Apr; 24(4):483-490. PubMed ID: 30518614
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The
Aagaard T; Reekie J; Roen A; Daugaard G; Specht L; Sengeløv H; Mocroft A; Lundgren J; Helleberg M
Int J Cancer; 2020 Jan; 146(2):321-328. PubMed ID: 30839100
[TBL] [Abstract][Full Text] [Related]
6. Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models.
Du X; Min J; Shah CP; Bishnoi R; Hogan WR; Lemas DJ
Int J Med Inform; 2020 Jul; 139():104140. PubMed ID: 32325370
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Risk Factors, and Outcomes of Febrile Neutropenia in Thai Hematologic Malignancy Patients Receiving Chemotherapy: A 6-year Retrospective Cohort Study.
Limvorapitak W; Khawcharoenporn T
Asian Pac J Cancer Prev; 2015; 16(14):5945-50. PubMed ID: 26320477
[TBL] [Abstract][Full Text] [Related]
8. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database.
Kim D; Lee S; Youk T; Hong S
Yonsei Med J; 2021 Jun; 62(6):479-486. PubMed ID: 34027634
[TBL] [Abstract][Full Text] [Related]
10. [Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database].
Freyer G; Scotte F; Borget I; Bruyas A; Vainchtock A; Chouaid C
Bull Cancer; 2016 Jun; 103(6):552-60. PubMed ID: 27233367
[TBL] [Abstract][Full Text] [Related]
11. Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer.
Keum J; Lee HS; Kang H; Jo JH; Chung MJ; Park JY; Park SW; Song SY; Bang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):651-659. PubMed ID: 32185483
[TBL] [Abstract][Full Text] [Related]
12. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings.
Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A
Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997
[TBL] [Abstract][Full Text] [Related]
13. Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations.
Faqeer NA; Mashni O; Dawoud R; Rumman A; Hanoun E; Nazer L
J Clin Pharmacol; 2017 Feb; 57(2):275-279. PubMed ID: 27479828
[TBL] [Abstract][Full Text] [Related]
14. Risk of mortality in patients with cancer who experience febrile neutropenia.
Lyman GH; Michels SL; Reynolds MW; Barron R; Tomic KS; Yu J
Cancer; 2010 Dec; 116(23):5555-63. PubMed ID: 20715160
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia.
Gunderson CC; Erickson BK; Wilkinson-Ryan I; Vesely SK; Leath CA; Gehrig PA; Moore KN
Am J Clin Oncol; 2019 Feb; 42(2):138-142. PubMed ID: 30557164
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropenia.
Lal A; Bhurgri Y; Rizvi N; Virwani M; Memon RU; Saeed W; Sardar MR; Kumar P; Shaikh AJ; Adil S; Masood N; Khurshed M
Asian Pac J Cancer Prev; 2008; 9(2):303-8. PubMed ID: 18712980
[TBL] [Abstract][Full Text] [Related]
17. Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy.
Chia VM; Page JH; Rodriguez R; Yang SJ; Huynh J; Chao C
Breast Cancer Res Treat; 2013 Apr; 138(2):621-31. PubMed ID: 23468242
[TBL] [Abstract][Full Text] [Related]
18. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
[TBL] [Abstract][Full Text] [Related]
19. Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia.
Kim M; Ahn S; Kim WY; Sohn CH; Seo DW; Lee YS; Lim KS
Support Care Cancer; 2017 May; 25(5):1557-1562. PubMed ID: 28062972
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Febrile Neutropenia in Children With Solid Tumors Treated With Cisplatin-based Chemotherapy.
Castelán-Martínez OD; Rodríguez-Islas F; Vargas-Neri JL; Palomo-Colli MA; López-Aguilar E; Clark P; Castañeda-Hernández G; Rivas-Ruiz R
J Pediatr Hematol Oncol; 2016 Apr; 38(3):191-6. PubMed ID: 26907640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
